BioAge Labs, Inc. (BIOA) vs Canopy Growth Corporation (CGC)
- BioAge Labs, Inc. BIOA 4.82 −9.91%
- Canopy Growth Corporation CGC 0.71 −4.05%
BioAge Labs, Inc. and Canopy Growth Corporation are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation is the larger, with a market value of $311.2M against $245.6M — 1.3× the size. Canopy Growth Corporation has the higher net margin (−80.4% vs −912.3%) and the higher return on invested capital (−17.2% vs −118.3%). Across the 16 metrics below, Canopy Growth Corporation leads on 9 and BioAge Labs, Inc. on 7.
Valuation
Profitability
| Metric | BIOA | CGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 25.16% | 53.94% |
| Operating margin | (1,026.28%) | (54.89%) | 0.00% |
| Net margin | (912.25%) | (80.39%) | 0.00% |
| Free cash flow margin | (2,345.11%) | (28.34%) | 0.00% |
| Return on equity | (28.21%) | (40.14%) | (0.40%) |
| Return on assets | (26.27%) | (23.54%) | (3.32%) |
| Return on invested capital | (118.25%) | (17.19%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack